angiomax

Generic: bivalirudin

angiomax: developed by 1 company. Updated within the last hour.

Development Pipeline (1)

CompanyPhase
SCICLONE PHARMACEUTICALS INC (SCLN)Phase 3

Get deeper analysis on angiomax

Full trial data, mechanism of action, competitive landscape, and AI-powered insights.

Start Free Analysis
    angiomax — Drug Pipeline, Trials & FDA Status | BioSniper